미국 비타민 K 복합체 보충제 공급업체 및 가격 — 마켓 오버뷰 2026

상위 제품

비타민 K 보충제

최종 업데이트

2026-08-02

서치 및 소싱 팀을 위한 핵심 요약

미국의 비타민 K 복합체 보충제 마켓 인텔리전스 페이지에는 프리미엄 공급업체 0개가 포함되어 있습니다.
미국에 대한 샘플 수출 거래 0건이 요약되어 있습니다.
미국의 비타민 K 복합체 보충제에 대해 수출 파트너 기업 0개와 수입 파트너 기업 1개가 매핑되어 있습니다.
도매 샘플 항목: 0건; 산지가 샘플 항목: 0건.
수출 파트너 국가 0개와 수입 파트너 국가 0개가 랭킹되어 있습니다.
페이지 데이터 최종 업데이트일: 2026-08-02.

미국의 비타민 K 복합체 보충제 수입 바이어 인텔리전스 및 가격 시그널: 바이어, 수요, 거래 파트너

미국의 비타민 K 복합체 보충제에 대해 수입 파트너 기업 1개가 추적됩니다. 수출업체와 수입업체는 Supply Chain Intelligence 회사 프로필 및 분석을 활용해 바이어 수요, 파트너 밀도, 다운스트림 채널을 분석할 수 있습니다.

스캐터 포인트는 전체 거래 데이터셋의 100.0%에서 샘플링되었습니다.

비타민 K 복합체 보충제의 미국 샘플 수입 거래 및 가격 기록

미국의 비타민 K 복합체 보충제 샘플 수입 거래 5건은 가격 수준과 수요 측 거래 패턴 벤치마킹을 위한 날짜, 원산지, 무역 국가 맥락을 제공합니다.

미국의 비타민 K 복합체 보충제 샘플 수입 거래 단가(일자별): 2025-12-22: 22.75 USD / kg, 2025-12-01: 15.20 USD / kg, 2025-11-14: 5.72 USD / kg, 2025-11-01: 5.72 USD / kg, 2025-11-01: 14.52 USD / kg.

일자	신고 품목	단가	수출업체	수입업체	원산지
2025-12-22	. K* ******* * **** * * * *********** ***** ****** ** ******** ******** *** ** ** ** ****** ***** * * ** ***** * ***** * ********* * *****	22.75 USD / kg	(-)	(-)	-
2025-12-01	MEN**** ** ***** * ** **** ** * ***** * **** ***** * ****** * **** * * ***** *** * ************** ** * ***** * *** ***** * ****** * * * *** * ********* ***** * ***** * ************ ******* * ** *** * ***** ** * * ***** *****	15.20 USD / kg	(-)	(-)	-
2025-11-14	VIT**** * ***** *** * *******	5.72 USD / kg	(-)	(-)	-
2025-11-01	VIT**** * *******	5.72 USD / kg	(-)	(-)	-
2025-11-01	VIT**** * *******	14.52 USD / kg	(-)	(-)	-

미국 내 상위 비타민 K 복합체 보충제 바이어, 수입업체 및 수요 파트너

선도 바이어 프로필을 검토하고 미국의 비타민 K 복합체 보충제에 대해 추적되는 전체 수입 파트너 기업 1개와 비교하세요. 수출업체와 수입업체는 Supply Chain Intelligence 회사 프로필 및 분석으로 수요 측 파트너 적합도를 평가할 수 있습니다.

(미국)

최근 수입 거래: 2026-07-02

임직원 규모: 직원 101 - 500명

매출액: 매출 USD 10M - 50M

산업군: 음료 제조식품 제조식품 포장

밸류체인 역할: 유통 / 도매식품 제조

미국 수입 파트너 커버리지

1개 기업

수입 파트너 기업 수는 미국의 비타민 K 복합체 보충제 수요 측 가시성을 보여줍니다.

공급망 인텔리전스 분석과 기업 프로필을 활용해 미국에서 활동 중인 비타민 K 복합체 보충제 수입업체, 유통업체, 바이어 네트워크를 식별하세요.

Classification

Product TypeProcessed Food

Product FormOral dietary supplement (tablet/capsule/softgel)

Industry PositionFinished Dietary Supplement (Consumer Health Product)

Market

In the United States, vitamin K complex supplements are marketed as dietary supplements, commonly using vitamin K1 (phylloquinone) and/or vitamin K2 forms (menaquinones such as MK-4 and MK-7). FDA does not pre-approve dietary supplements for safety and effectiveness before marketing; companies are responsible for ensuring products are not adulterated or misbranded and for complying with dietary supplement cGMPs (21 CFR Part 111) and labeling requirements (e.g., “Supplement Facts”). Claims strategy is a key market-access constraint: structure/function and related claims require the DSHEA disclaimer and a post-market notification to FDA, while disease claims can trigger enforcement risk. For imports of finished supplements and dietary ingredients, FDA prior notice is required and inadequate prior notice can lead to refusal/hold at the port of entry. Because vitamin K can interact with certain anticoagulant medications, responsible labeling and consumer communication are important risk-management considerations in this category.

Market RoleLarge domestic consumer market with regulated dietary supplement industry; both domestic manufacturing and imports

Domestic RoleMainly consumer retail and e-commerce dietary supplement category; compliance-driven market access (labeling, cGMP, claims substantiation)

Specification

Physical Attributes

Dietary supplements are intended for ingestion (swallowed) and are commonly sold as tablets, capsules, softgels, powders, or liquids; vitamin K complex products are typically solid oral dosage forms.

Compositional Metrics

Label-declared vitamin K form(s) and potency (amount per serving) in Supplement Facts
Presence of “other ingredients” (e.g., excipients) listed outside Supplement Facts as required

Packaging

Retail unit packaging with required labeling elements (e.g., Supplement Facts, ingredient statement) and any required DSHEA disclaimer when structure/function claims are used

Supply Chain

Value Chain

Dietary ingredient sourcing (vitamin K forms) → incoming component controls → blending → encapsulation/tableting → packaging/label control → distribution to retail/e-commerce

Freight IntensityLow

Transport ModeMultimodal

Risks

Regulatory Compliance HighU.S. market access can be blocked or severely disrupted by FDA enforcement and import actions if a vitamin K complex supplement is deemed adulterated or misbranded, or if required compliance steps (e.g., dietary supplement cGMP controls, labeling requirements, or import prior notice) are not met.Operate to 21 CFR Part 111 cGMP with documented QC and batch records; validate label/claims workflows; for imports, ensure accurate and timely FDA Prior Notice and maintain an import compliance checklist aligned to FDA requirements.

Claims and Advertising HighImproper disease claims or insufficient scientific substantiation for advertised benefits can trigger regulatory and legal risk; structure/function and related label claims require the DSHEA disclaimer and a post-market notification to FDA.Use compliant claim types and include the required disclaimer; submit structure/function claim notifications on time; maintain substantiation files aligned with FTC guidance for health-related advertising claims.

Import Controls MediumImported dietary supplements and dietary ingredients require FDA Prior Notice; inadequate prior notice can result in refusal and the shipment being held at the port of entry, creating service-level failures and inventory disruption.Implement broker SOPs for Prior Notice (PNSI or ABI/ACE), including data validation and exception handling; pre-align product identifiers, manufacturer details, and labeling documentation with the entry filing.

Consumer Safety MediumVitamin K can interact with certain medications (notably anticoagulants), creating reputational and product-liability risk if consumer communication and labeling practices are inadequate or misleading.Use clear, non-misleading labeling and consumer guidance consistent with allowable supplement labeling frameworks; ensure customer service and adverse-event handling processes are in place and documented.

Standards

USP Dietary Supplement Verification Program (USP Verified Mark) (voluntary)
NSF/ANSI 173 dietary supplement certification (voluntary)
NSF Certified for Sport® (voluntary, banned-substance focused)

FAQ

Does the FDA approve vitamin K complex supplements before they are sold in the United States?No. Under DSHEA, FDA is not authorized to approve dietary supplements for safety and effectiveness before they are marketed. Companies are responsible for ensuring their products are not adulterated or misbranded and comply with applicable requirements.

If a vitamin K complex supplement label uses a structure/function claim, what additional FDA step is required?Structure/function (and related) claims require the DSHEA disclaimer on the label, and the responsible firm must notify FDA about the claim within 30 days after first marketing the dietary supplement with the claim.

When is a New Dietary Ingredient (NDI) notification relevant for U.S. dietary supplements?If a product contains a “new dietary ingredient” (generally, a dietary ingredient not marketed in the U.S. in a dietary supplement before October 15, 1994), the manufacturer or distributor may need to submit a premarket safety notification to FDA at least 75 days before introducing the product into interstate commerce, depending on the ingredient’s status and conditions described by FDA.

Which forms of vitamin K are commonly referenced for supplements in the U.S. market?Vitamin K supplements commonly reference vitamin K1 (phylloquinone) and vitamin K2 (menaquinones). Menaquinones are designated MK-4 through MK-13; MK-4 and MK-7 are among the most studied.